Fla. Stat. 408.0621
Blood clot and pulmonary embolism policy workgroup
(1)
The Secretary of Health Care Administration, in conjunction with the State Surgeon General, shall establish a blood clot and pulmonary embolism policy workgroup.(2)
The workgroup shall:Identify the aggregate number of people who experience blood clots and pulmonary embolisms each year in this state.Identify how data is collected regarding blood clots, pulmonary embolisms, and adverse health outcomes associated with these conditions.Identify how blood clots and pulmonary embolisms impact the lives of people in this state.Identify the standards of care for blood clot surveillance, detection, and treatment.Identify emerging treatments, therapies, and research relating to blood clots.Develop a risk surveillance system to help health care providers identify patients who may be at a higher risk of forming blood clots and pulmonary embolisms.Develop policy recommendations to help improve patient awareness of blood clot risks.Develop policy recommendations to help improve surveillance and detection of patients who may be at a higher risk of forming blood clots in licensed health care facilities, including hospitals, nursing homes, assisted living facilities, residential treatment facilities, and ambulatory surgical centers.Develop policy recommendations relating to guidelines used that affect the standard of care for patients at risk of forming blood clots.Develop policy recommendations relating to providing patients and their families with written notice of increased risks of forming blood clots.(a)
Identify the aggregate number of people who experience blood clots and pulmonary embolisms each year in this state.(b)
Identify how data is collected regarding blood clots, pulmonary embolisms, and adverse health outcomes associated with these conditions.(c)
Identify how blood clots and pulmonary embolisms impact the lives of people in this state.(d)
Identify the standards of care for blood clot surveillance, detection, and treatment.(e)
Identify emerging treatments, therapies, and research relating to blood clots.(f)
Develop a risk surveillance system to help health care providers identify patients who may be at a higher risk of forming blood clots and pulmonary embolisms.(g)
Develop policy recommendations to help improve patient awareness of blood clot risks.(h)
Develop policy recommendations to help improve surveillance and detection of patients who may be at a higher risk of forming blood clots in licensed health care facilities, including hospitals, nursing homes, assisted living facilities, residential treatment facilities, and ambulatory surgical centers.(i)
Develop policy recommendations relating to guidelines used that affect the standard of care for patients at risk of forming blood clots.(j)
Develop policy recommendations relating to providing patients and their families with written notice of increased risks of forming blood clots.(3)(a)
The workgroup shall be composed of health care providers, patients who have experienced blood clots, family members of patients who have died from blood clots, advocates, and other interested parties and associations.The President of the Senate and the Speaker of the House of Representatives shall each appoint two members to the workgroup.Members of the workgroup shall serve without compensation.The State Surgeon General shall appoint the chair of the workgroup.The chair is authorized to create subcommittees to help with research, scheduling speakers on important subjects, and drafting a workgroup report and policy recommendations.Meetings of the workgroup may be held through teleconference or other electronic means.(3)(a)
The workgroup shall be composed of health care providers, patients who have experienced blood clots, family members of patients who have died from blood clots, advocates, and other interested parties and associations.(b)
The President of the Senate and the Speaker of the House of Representatives shall each appoint two members to the workgroup.(c)
Members of the workgroup shall serve without compensation.(d)
The State Surgeon General shall appoint the chair of the workgroup.(e)
The chair is authorized to create subcommittees to help with research, scheduling speakers on important subjects, and drafting a workgroup report and policy recommendations.(f)
Meetings of the workgroup may be held through teleconference or other electronic means.(4)(a)
The Secretary of Health Care Administration shall submit an annual report detailing his or her findings and recommendations to the Governor, the President of the Senate, and the Speaker of the House of Representatives.The Secretary of Health Care Administration shall submit a final report detailing his or her findings and recommendations to the Governor, the President of the Senate, and the Speaker of the House of Representatives by January 4, 2025.(4)(a)
The Secretary of Health Care Administration shall submit an annual report detailing his or her findings and recommendations to the Governor, the President of the Senate, and the Speaker of the House of Representatives.(b)
The Secretary of Health Care Administration shall submit a final report detailing his or her findings and recommendations to the Governor, the President of the Senate, and the Speaker of the House of Representatives by January 4, 2025.
Source:
Section 408.0621 — Blood clot and pulmonary embolism policy workgroup, https://www.flsenate.gov/Laws/Statutes/2024/0408.0621 (accessed Aug. 7, 2025).